In a retrospective study of 4,294 consecutive postmortem cases, there were 15 with histologically proved sarcoidosis, including 4 with CNS involvement. Whereas in previously reported autopsy series the prevalence of neurosarcoidosis was 15%, it is 27% in this review. Five cases with incidental, clinically inapparent sarcoidosis died at a mean age of 54.6 years; those six with systemic sarcoidosis, not involving the CNS, died at a mean age of 47.0 years; while those four with a variety of neurologic manifestations in addition to systemic sarcoidosis died at a mean age of 38.2 years. Thus, it appears that at one end of the spectrum of morbidity, sarcoidosis may cause no or only trivial symptoms and permit prolonged survival. At the other extreme, sarcoidosis may affect a younger population more severely. CNS involvement occurs relatively early in the course and is rather rapidly progressive, accounting for the poor prognosis, despite appropriate medical and neurosurgical management. In its turn, neurosarcoidosis may present with a variety of signs and symptoms, depending on the site of involvement along the craniospinal axis. This feature is illustrated by the manifestations of compression myelopathy, hydrocephalus with dementia, hydrocephalus with seizures and ataxia, and anosmia, blindness, seizures, and diabetes insipidus. In addition, one patient developed a Nocardia brain abscess as a complication of the altered immune system in sarcoidosis. RESUME: Nous avons trouve 15 cas de sarcoidose prouves histologiquement, dont 4 avec atteinte du SNC, dans une etude retrospective de 4294 cas consecutifs d'autopsie. Dans les etudes prealablement publiees, la prevalence de neurosarcoidose etait de 15% alors qu'elle est de 27% dans la presente serie. Chez les 5 patients dont la sarcoidose etait cliniquement inapparente, la mort s'est produite a l'age moyen de 54.6 ans; chez les 6 patients avec sarcoidose systemique, mais sans atteinte neurologique, l'age moyen du deces etait de 47.0 ans; enfin, chez les 4 patients presentant des manifestations neurologiques et une sarcoidose systemique, l'age moyen du deces est de 35.0 ans. II semble done qu'a une extremite de l'eventail morbide, la sarcoidose peut etre silencieuse et permettre une longue survie; tandis qu'a l'autre extremite la sarcoidose peut atteindre plus severement une population plus jeune. L'atteinte du SNC se produit generalement relativement tot et est rapidement progressive, ce qui explique le mauvais pronostic malgre les traitements medicaux et chirurgicaux appropries. La neurosarcoidose peut se presenter de facon tres variee selon le site d'atteinte le long de l'axe cranio-spinal et imiter: une myelopathic compressive, une hydrocephalic avec demence, une hydrocephalic avec epilepsie et ataxie; anosmie, cecite, crises epileptiques, diabete insipide, troubles neuropsychiatriques, diplopie et troubles neuroendocriniens. On autre patient, dont le systeme immun etait altere par la sarcoidose, a developpe un abces cerebral a la Nocardia.
As a granulomatous disease of undetermined etiology but with a significant component of immune dysregulation, sarcoidosis may affect any tissue. Involvement of the central nervous and neuromuscular systems has been reported with some frequency (Aszkanazy, 1952; Day and Sypert, 1977; Delaney, 1977; Waxman and Sher, 1979) . Commonly, "sarcoidosis of the nervous system" has been applied collectively to cases with involvement of the craniospinal axis and of the peripheral nervous and muscular systems. It has also been taught empirically that neurosarcoidosis has a much poorer prognosis for quality of survival and longevity when compared to other forms of the disease. Through a retrospective postmortem review, I wish to illustrate this trend and the clinico-pathologic correlation.
MATERIALS AND METHODS
Postmortem records at Georgetown University Hospital (GUH) for the years 1966 to 1981 were reviewed to select cases listing sarcoidosis as a histopathologic diagnosis. Among the 4,294 postmortem cases, there were 19 so classified. Four cases were excluded because non-caseating or obsolescent granulomas were confined to a single mediastinal or hilar lymph node or the spleen. The remaining 15 cases (12 Black, 3 White; 8 male, 7 female) form the basis of this study.
Whenever the clinical abstract in the autopsy protocol was incomplete, the patient's entire hospital records were reviewed. Histologic slides, stained with a battery of histochemical procedures, were studied.
RESULTS
The prevalence of sarcoidosis in the 4,294 postmortem cases was 15, or 0.35%. These 15 cases are grouped into three major categories.
I. Incidental, postmortem diagnosis of sarcoid granulomas: 5 cases, having a mean age of 54.6 years (range, 40 to 77 years; 3 males, 2 females; 3 Black, 2 White). II. Systemic sarcoidosis, clinically manifest, proved by biopsy, and confirmed postmortem: 6 cases, with a mean age of 47.0 years (range, 28-72 years; 2 males, 4 females; 5 Black, one White). The mean duration of sarcoidosis for this group was 6.7 years (range, 2 to 12 Table 1 ): 4 cases, having a mean age of 38.2 years (range, 27 to 61 years; 3 males, 1 female; all were Black). The total course of sarcoidosis averaged 7.2 years (range, 4 to 14 years) with a mean duration of CNS symptomatology of 4.0 years (range, 3 months to 10 years). The prevalence of neurosarcoidosis in this series of 15 postmortem cases of sarcoidosis at GUH over a 15-year period is thus 4/15 or 27%.
CASE REPORTS

Case 1
An epileptic Black man with moderate mental retardation was discovered to have a left hilar lymphadenopathy and bilateral pneumonitis on chest X-rays at age 23 years. Lack of radiographic resolution with antibiotic therapy prompted a liver biopsy, which demonstrated noncaseating epithelioid granulomas. Approximately three months prior to death at age 27 years, he became progressively more demented and spastic. He died of staphylococcal abscess in the upper lobe of the right lung after several days of fever. Massive, generalized lymphadenopathy was due to epithelioid and giant cell granulomas and hyaline nodular fibrosis. Liver, spleen, lungs and thoracic vertebrae also contained multiple granulomas. The midthoracic vertebrae were pathologically fractured. The lentiform nuclei were partly destroyed by numerous epitheloid cell granulomas containing giant cells and lymphocytes. Special stains fail to disclose microorganisms.
Case 2 An admission chest X-ray disclosed bilateral hilar and mediastinal lymphadenopathy in a 57 year old Black man. Cervical lymph node biopsy demonstrated granulomas consistent with sarcoidosis. Two years later, pancytopenia secondary to splenomegaly from sarcoidosis necessitated splenectomy. Several months later he was readmitted for progressive dyspnea, weakness, anorexia, weight loss, lethargy, and dementia. Lumbar puncture revealed clear CSF under normal pressure but containing 231 mg % protein and 52 mg % glucose. Diffuse slowing of electrical activity was evident on the EEG, but bilateral carotid arteriography was unremarkable. After a further year, he developed gait disturbances and memory loss. Vertical nystagmus and bilateral Babinski responses were detected. The CSF protein was 391 mg % and glucose 34 mg %. Despite steroid therapy, his level of consciousness fluctuated and he had occasional grand mal seizures only partly controlled with Dilantin. At age 61 years, he was found at home with a high fever due to bilateral bronchopneumonia and expired on the day of admission.
Innumerable sclerosing and hyalinized granulomas were scattered through multiple lymph node groups, liver, cranial and spinal leptomeninges, anterior and posterior spinal nerve roots, and cerebral ventricular walls.
Case 3
Hilar lymphadenopathy was the first evidence of sarcoidosis in a 24-year old Black man. Four years later, focal and generalized tonic/clonic seizures appeared. Twelve years after the diagnosis of sarcoidosis, he suffered intermittent gait ataxia secondary to hydrocephalus; the CSF contained elevated protein and gammaglobulin. Isotope cisternography disclosed subarachnoid block in the ambient and interpenducular cisterns. A ventriculoatrial shunt was placed. On the first postoperative day he complained of slight headache, became confused and lethargic, and was found without vital signs some hours later. Sarcoid granulomas involved the lungs, hilar lymph nodes, spleen, pancreas, and leptomeninges. especially those about the outflow foramina from the fourth ventricule, and caused hydrocephalus ( A 23-year old Black woman had uveitis and dyspnea due to sarcoidosis; she was treated with topical and systemic steroids, but developed complete blindness within 3 years. She developed amenorrhea, headaches, lethargy, and grand mal seizures. Lumbar puncture procured CSF at an opening pressure exceeding 600 mm water; protein was 143 mg/dl, glucose 30 mg/dl, and there were 30 lymphocytes; smear and cultures were negative. Brain scan revealed increased uptake over both hemispheres. Anticonvulsants provided good seizure control. Subsequent admissions over 3 years were for diabetes insipidus, elevated intracranial pressure, neuroendocrine abnormalities, and dysosmia. CSF was now xanthochromic, with pressure of 240 mm water, protein of 635 mg/dl, glucose of 20 mg/dl, and no cells. Cranial CT scan demonstrated enlarged ventricles. Terminally, she acquired an atypical scotochromogenic mycobacterial ulcer of the sacrum and hip. She suffered a cardiorespiratory arrest after aspiration.
Postmortem study revealed systemic sarcoidosis. The brain weighed 1050 gm. The basal meninges were markedly fibrotic and multiple cranial nerves were severely atrophic or infiltrated by granulomas (Fig. 2) . The pituitary gland weighed only 280 mg. and was largely replaced by fibrous scar tissue. Most of the hypothalamus was gliotic or was occupied by obsolescent and epithelioid cell granulomas. The spinal cord (Fig. 3) and nerve roots were affected. Leptomeningeal cultures were negative and special stains of the intracranial contents failed to demonstrate microorganisms. Multiple organs and tissues contained sarcoid granulomas. The brain weighed 1695 gm, the blood vessels were congested, and the basal leptomeninges granular and thickened, trapping the cranial nerves (Fig. 4) . All components of the craniospinal axis were extensively infiltrated by sarcoid granulomas, so as to obliterate the fourth ventricular outflow foramina (Fig. 5) and to strangle cranial nerves. The hypophysis was largely destroyed (Fig. 6) . Special stains and electron microscopy failed to demonstrate microorganisms. Several arteries and veins exhibited granulomatous angiitis, fibrinoid necrosis, and thrombosis (Fig. 7) . A portion of occipital lobe was infarcted. 
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DISCUSSION
The prevalence of clinically manifest sarcoidosis of the nervous system in patients with the systemic disease has ranged from 1% (Douglas and Maloney, 1973) , to 4.3% (Slade, 1979) , to 16% (Maycock et al, 1963) . In postmortem series, neurosarcoidosis has been reported in approximately 15% (Aszkanazy, 1952; Ricker and Clark, 1949; Waxman and Sher, 1979) . Waxman and Sher (1979) have emphasized that granulomas consistent with sarcoidosis of the central nervous system are readily identified at necropsy in clinically asymptomatic cases, illustrating this phenomenon in two of their five cases. One must however, keep in mind the dictum that " . . . the diagnosis is established most securely when clinicoradiographic findings are supported by histological evidence of wide-spread noncaseating epithelioid cell granulomas in more than one organ..." (James et al, 1976) . On the one hand, as is evident from the clinical literature cited above, neurosarcoidosis is a relatively uncommon manifestation of systemic dissemination of this granulomatous process. On the other hand, it may be the first or only clinical or pathological evidence of the disease. However, in the latter situation, there is the inherent problem of nosologic definition, since the differential diagnosis of granulomatous diseases is extremely broad (James and Neville, 1977) .
If one downplays the "clinicoradiographic" findings and emphasizes the histologic criteria of non-caseating or hyalinized granulomas in several organs (James et al, 1976) , my data seem to indicate that there may be clinically asymptomatic cases of sarcoidosis. The five cases in category I might constitute one end of the spectrum of sarcoidosis with no or only insignificant symptoms and spontaneous arrest with prolonged survival. These incidental cases had a mean age of 54.6 years at death from other causes. Those in category II with clinically apparent sarcoidosis, but no involvement of the CNS, died at an appreciably younger age (mean of 47.0 years) after an average duration of the disease of 6.7 years. Those patients, in category III, who had neurologic manifestations of sarcoidosis, died at a still younger age (mean, 38.2 years). After an interval averaging 3.2 years, their systemic sarcoidal process also affected the CNS, with a further mean course of 4.0 years of progressive and additive neurologic deficits. This third group then appears at the other end of the spectrum of sarcoidosis, with onset at a younger age, involvement of the CNS early in the course of the disease, poor response to medical and/or neurosurgical modalities of therapy, and fairly rapid progression to death.
Where appropriate data were provided, similar trends can be calculated from published postmortem studies. In Ricker and Clark's (1949) series, the three patients with CNS involvement died at a mean age of 24 years contrasted with 17 patients without CNS involvement whose death occurred at an average of 31 years. In the seven cases of neurosarcoidosis of Herring and Urich (1969) , the mean age at death was 37.4 years, with an average total duration of sarcoidosis of 8.3 years and of neurosarcoidosis of 4.7 years. Waxman and Sher (1979) reported five cases, having an average age of 33.2 years at death and a disease course of 2.3 years. Significantly, the two cases of incidental sarcoidosis of the cranial leptomeninges were the oldest patients, namely 43 and 50 years, in their series. This finding suggests that even neurosarcoidosis may span a spectrum, ranging from insignificant or no clinical manifestation to the most aggressive and fulminating form.
Many publications have emphasized the variety of syndromes caused by sarcoidosis of the CNS. The predilection of this granulomatous process for the leptomeninges at the cranial base accounts for the predominance of cases with neuroendocrine dysfunction due to involvement of hypothalamus, pituitary stalk, and hypophysis (Stuart et al, 1978) ; with cranial nerve palsies (Colover, 1948) ; with hydrocephalus (Kumpe et al, 1979) ; and with neuropsychiatric manifestations (Gilmore et al, 1980) . A meningoencephalomyelitic process may cause various neurologic deficits and/or elevated intracranial pressure, spinal cord syndromes (Day & Sypert, 1977) , spinal nerve and nerve root disturbances, and large, tumor-like intracranial granulomatous masses (Delaney, 1977) . As an additional pecularity, extending over months to years, the disease process is subject to remissions (either spontaneously or with treatment) and to relapses, but generally it runs a progressive course. Further, involvement of non-neural organs and systems by sarcoidal granulomas may cause metabolic, endocrinologic, and structural deficits which may secondarily affect the CNS. Vasculitis and cerebral infarcts have also been reported (Herring & Urich, 1969) . Finally, the systemic immune derangement in sarcoidosis facilitates infection of the CNS by opportunistic microbiologic agents (Mathews et al, 1976) .
